Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors

Схожие документы

• Therapeutic Strategies Utilized in the Setting of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors
  по: Yu, Helena A., et al.
  Опубликовано: (2014)
• Combating acquired resistance to tyrosine kinase inhibitors in lung cancer
  по: Lovly, Christine M.
  Опубликовано: (2015)
• Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
  по: Xu, Haiyuan, et al.
  Опубликовано: (2019)
• Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations
  по: Arrieta, Oscar, et al.
  Опубликовано: (2020)
• Treatment‐free remission with first‐ and second‐generation tyrosine kinase inhibitors
  по: Cortes, Jorge, et al.
  Опубликовано: (2018)